United States · Seed startup

Who invested in Ventricle Health

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Healthcare

Funding summaryUpdated 26 Oct 2026

$8.0Mraised across 1 round since 2023, from 1 source

Latest round
Seed, $8.0MOct 2023
Investors
1
See who backed them

The rounds

  1. Oct 2023
    Seed$8.0M

    Source recordedSEC filing: $8.0M sold, first sale Sept 2023

Founders and team

From the SEC filings it signed: 3 on the team.

  • Daniel BensimhonChief Medical Officeri
  • Carie CotterTreasureri
  • Sean O'DonnellExecutive Officer, Directori

On the board, as filediAnurag KondapalliMatthew Soule

Everyone who backed them

RA Capital ManagementPrivate equity1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Ventricle Health as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

Waterline VenturesVC firmPer its own site

Quick answers about Ventricle Health

Who invested in Ventricle Health?

Ventricle Health's investors include RA Capital Management.

How much has Ventricle Health raised?

Ventricle Health has raised $8.0M across 1 round since 2023.

When did Ventricle Health last raise?

Ventricle Health's most recent round was a Seed of $8.0M in Oct 2023.

What was Ventricle Health's biggest round?

Its most recent round, $8.0M in Oct 2023, is also its largest on record.

Who backed Ventricle Health first?

Ventricle Health's first round on record, in Oct 2023, was backed by RA Capital Management.

What stage is Ventricle Health at?

Ventricle Health's latest named round is a Seed, in Oct 2023.

Where is Ventricle Health based?

Ventricle Health is based in the United States.

Companies like Ventricle Health

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.